| ADR Ontology |
| ADR Term |
Blastomycosis |
| ADR ID |
BADD_A00481 |
| ADR Hierarchy |
|
| Description |
A fungal infection that may appear in two forms: 1, a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2, chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung. [MeSH] |
| MedDRA Code |
10005098 |
| MeSH ID |
D001759
|
|
ADR Severity Grade (FAERS)
|
Not Available
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Blastomyces dermatitidis infection | Blastomycosis | Blastomycotic infection | Blastomycosis recurrent | Blastomycoses | Blastomycosis, North American | North American Blastomycosis | Gilchrist Disease | Gilchrist's Disease | Gilchrists Disease |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00194 | Azacitidine | - | - | | BADD_D00416 | Certolizumab pegol | - | - |
| The 1th Page 1
Total 1 Pages
|
|
